You might also like:
In the media
Giovanni Cincilla discusses Unveiling Biological Targets with KNIME in a new Blog series on Medium

News & Opinion
Healx Appoints Christopher Moertel as Global Head of Clinical Development
News & Opinion
Healx Announces First Patient Dosed in Phase 2 Trial Evaluating HLX-1502 for the Treatment of Neurofibromatosis Type 1